A genetic association between β3-aderenoceptor and cholinergic receptor muscarinic 3 polymorphisms in irritable bowel syndrome

Hepato-Gastroenterology

Volumn 58, Issue 110-111, 2011, Pages 1474-1478

  Onodera, Saori ^a   Chiba, Toshimi ^a   Sugai, Tamotsu ^a   Habano, Wataru ^a  

^a IWATE MEDICAL UNIVERSITY   (Japan)

Author keywords

3 adrenoceptor; Cholinergic receptor muscarinic 3; Irritable bowel syndrome

Indexed keywords

BETA 3 ADRENERGIC RECEPTOR; CHOLINERGIC RECEPTOR; DNA; MUSCARINIC M3 RECEPTOR;

ADULT; ARTICLE; CONSTIPATION; CONTROLLED STUDY; DIARRHEA; DISEASE DURATION; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; IRRITABLE COLON; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; AGED; ALLELE; CASE CONTROL STUDY; CHI SQUARE DISTRIBUTION; COMORBIDITY; GENETICS; MIDDLE AGED; STATISTICAL MODEL;

AGED; ALLELES; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; COMORBIDITY; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; IRRITABLE BOWEL SYNDROME; LOGISTIC MODELS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RECEPTOR, MUSCARINIC M3; RECEPTORS, ADRENERGIC, BETA-3;

EID: 83355174177     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Drossman DA, Dumitrascu DL: Rome III: New standard for functional gastrointestinal disorders. J Gastrointestin Liver Dis 2006; 15:237-241. (Pubitemid 44483091)
2. Fukudo S, Hongo M: On the organ choice in psychosomatic disorders. Irritable bowel syndrome: a disorder of abnormal brain-gut interactions. Japan J Psychosomat Med 1999; 39:159-166. (Pubitemid 29082620)
3. Adam B, Liebregts T, Holtmann G: Mechanisms of disease: genetics of irritable bowel syndrome. Clin Gastroentrol Hepatol 2005; 3:1057-1065.
4. Uchiyama T, Chess-Williams R: Muscarinic receptor subtypes of the bladder and gastrointestinal tract. J Smooth Muscle Res 2004; 40:237-247. (Pubitemid 40364079)
5. Lipworth BJ: Clinical pharmacology of β3-adrenoceptors. Br J Clin Pharmacol 1996; 42:291-300.
6. Bianchetti A, Manara L: In vitro inhibition of intestinal motility by phenylethanolaminotetralines: evidence of atypical β-adrenoceptors in rat colon. Br J Pharmacol 1990; 100:831-839. (Pubitemid 20233327)
7. Bianchetti A, Manara L: A Atypical beta-adrenoceptors account for inhibition of rat colon motility and lipolytic action of phenylethanolaminotetralines. Eur J Pharmacol 1990; 183:2196-2197. (Pubitemid 20250150)
8. Tan S, Curtis-Prior PB: Characterization of the beta adrenoceptor of the adipose cell of the rat. Int J Obes 1983; 7:409-414. (Pubitemid 13020972)
9. Berkowitz DE, Nardone NA, Smiley RM, et al.: Distribution of β-3-adrenoceptor mRNA in human tissues. Eur J Pharmacol 1995; 289:223-228.
10. Roberts SJ, Papaioannou M, Evans BA, et al.: Functional and molecular evidence for β1-, β2- and β3-adreonoceptors in human colon. Br J Pharmacol 1997; 120:1527-1535. (Pubitemid 27192445)
11. Anthony A, Schepelmann S, Guillaume JL, et al.: Localization of the β3-adrenoceptor in the human gastrointestinal tract: an immunohistochemical study. Aliment Phamacol Ther 1998; 12:519-525. (Pubitemid 28289439)
12. Chamberian PD, Jennings KH, Paul F, et al.: The tissue distribution of the human β3-adrenoceptor in human adipose tissue, atrium and skeletal muscle. Int J Obes Relat Metab Disord 1999; 23:1057-1065.
13. Takezaki T, Hamajima N, Matsuo K, et al.: Association of polymorphisms in the beta-2 and beta-3 adrenoceptor genes with risk of colorectal cancer in Japanese. Int J Clin Oncol 2001; 6:117-122. (Pubitemid 32634489)
14. Kurabayasi T, Yahata T, Quan J, et al.: Association of polymorphisms in the beta2 and beta3 adrenoceptor gene with polycystic ovary syndrome. J Report Med 2006; 51:389-393. (Pubitemid 43765080)
15. Leineweber K, Bucher R, Brunck H, et al.: β-Adrenoceptor polymorphisms. Horm Metab Res 2004; 32:91-96.
16. Vrydag W, Alewijnse AE, Michel MC: Do gene polymorphisms alone or in combination affect the function of human beta3-adrenoceptors? Br J Pharmacol 2009; 156:127-134.
17. Hahntow IN, Koopmans RP, Michel MC: The β2-Adrenoceptor gene and hypertension. J Hypertension 2004; 24:1003-1007.
18. Hoffstedt J, Poirier O, Thorne A, et al.: Polymorphism of the human β3-adrenoceptor gene form a well-conserved haplotype that is associated with moderate obesity and altered receptor function. Diabetes 1999; 48:203-205. (Pubitemid 29019374)
19. Ramis M, Gonzales-Sanchez JL, Proenza AM, et al.: The Arg64 allele of the beta-3-adrenoceptor gene but not the -3826G allele of the uncoupling protein 1 gene is associated with increased leptin levels in the Spanish population. Metabolism 2004; 53:1411-1416. (Pubitemid 39410379)
20. Umekawa T, Yoshida T, Sakane N, et al.: Trp64Arg mutation of β3-adrenoceptor gene deteriorates lipolysis by β3-adrenoceptor agonist in human omental adipocytes. Diabetes 1999; 48:117-120. (Pubitemid 29019361)
21. Walston J, Silver K, Bogardus C, et al.: Time of onset of non-insulin-dependent diabetes mellitus and genetic variation in the β3-adrenogenic receptor gene. N Eng J Med 1995; 333:343-347.
22. Eglen RM, Hegde SS, Watson N, et al.: Muscarinic receptor subtypes and smooth muscle function. Pharmacol Rev 1996; 48:531-565. (Pubitemid 27023820)
23. Wallis RM, Napier CM: Muscarinic antagonists in development of disorders of smooth muscle function. Life Sci 1999; 64:395-406.
24. Thollander MS, Leelakusolvong S, Chiba T, et al.: Cholinergic control of colonic tone. Gastroenterology 1998; 114:A847.
25. Chiba T, Bharucha AE, Thomforde GM, et al.: Model of rapid gastrointestinal transit in dogs: effects of muscarinic antagonists and a nitric oxide synthase inhibitor. Neurogastroenterol Motil 2002; 14:535-541. (Pubitemid 35216337)
26. Guo Y, Traurig M, Ma L, et al.: CHRM3 Gene Variation Is Associated With Decreased Acute Insulin Secretion and Increased Risk for Early-Onset Type 2 Diabetes in Pima Indians. Diabetes 2006; 55:3625-3629. (Pubitemid 44923626)
27. Gibbons AS, Scarr E, McLean C, et al.: Decreased muscarinic receptor binding in the frontal cortex of bipolar disorder and major depressive disorder subjects. J Affect Disord 2009; 116:184-191.
28. McBrien NA, Jobling AI, Truong HT, et al.: Expression of muscarinic receptor subtypes in three shrew ocular tissue and their regulation during the development of myopia. Molecular Vision 2009; 15:464-475.
29. Van der Veek PP, van den Berg M, et al.: Role of Tumor Necrosis Factor -α and Interleukin-10 Gene Polymorphisms in Irritable Bowel Syndrome. Am J Gastroenterol 2005; 100:2510-2516.
30. Camilleri M, Atanasova E, Paula J, et al.: Serotonin-Transporter Polymorphism Pharmacogenetics in Diarrhea-Predominant Irritable Bowel Syndrome. Gastroenterology 2002; 123:425-432. (Pubitemid 34827186)
31. Kim HJ, Camilleri M, Carlson PJ, et al.: Association of distinct α2 adrenoceptor and serotonin transporter polymorphisms with constipation and somatic symptoms in functional gastrointestinal disorders. Gut 2004; 53:829-837. (Pubitemid 38662132)
32. Pata C, Erdal E, Yazici K, et al.: Association of the 1438 G/A and 102 T/C Polymorphism of the 5-Ht2A Receptor Gene with Irritable Bowel Syndrome 5-HT 2A Gene Polymorphism in Irritable Bowel Syndrome. J Clin Gastroenterol 2004; 38:561-566. (Pubitemid 38955412)
33. D'Amato M, Rovati LC: Cholecystokinin-A receptor antagonists: therapies for gastrointestinal disorders. Expert Opin Investig Drugs 1997; 6:819-836. (Pubitemid 27290619)
34. Croci T, Bianchetti A, Giudice A, et al.: Effects of SR 58611A and ritodrine on proximal colon myoelectrical activity, heart rate and blood pressure of conscious rats. J Gastrointestinal Motility 1989; 1,A47.
35. Giudice A, Croci T, Bianchetti A, et al.: Inhibition of rat colonic motility and cardiovascular effects of new gut-specific beta-adrenergic phenylethanolaminotetralines. Life Sci 1989; 44:1411-1417. (Pubitemid 19150100)
36. Taborsky GJ Jr., Ensimck JW : Contribution of the pancreas to circulating somatostatin-like immunoreactivity in the normal dog. J Clin Invest 1984; 73:216-223.
37. Bardou M, Dousset B, Deneux-Tharaux C, et al.: In vitro inhibition of human colonic motility with SR 59119A and SR 59104A: evidence of a β3-adrenoceptor-mediated effect. Eur J Pharmacol 1998; 353:281-287. (Pubitemid 28352275)
38. de Ponti F, Gibelli G, Croci T, et al.: Functional evidence of atypical β 3-adrenoceptor antagonist, SR 59230A. Br J Pharmacol 1996; 117:1374-1376.
39. Manara L, Crocci T, Aureggi G, et al.: Functional assessment of β adrenoceptor subtypes in human colonic circular and longitudinal (taenia coli) smooth muscle. Gut 2000; 47:337-342.
40. Cellek S, Thangiah R, Bassil A, et al.: Demonstration of functional neuronal β3-adrenoceptors within the enteric nervous system. Gastroenterology 2007; 133:175-183. (Pubitemid 47031143)
41. Holtmann G, Sifect W, Haag S, et al.: G-protein beta 3 subunit 825 CC genotype is associated with unexplained (functional) dyspepsia. Gastroenterology 2004; 126:971-979. (Pubitemid 38451168)
42. Uchiyama T, Chess-Wikkiams R: Muscarinic receptor subtypes of the bladder and gastrointestinal tract. J Smooth Muscle Res 2004; 40:237-247. (Pubitemid 40364079)
43. Lindqvist S, Hernon J, Sharp P, et al.: Acetylcholine-induced calcium signaling along the rat colonic crypt axis. Br J Pharmacol 2002; 137:1134-1142.